U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550478) titled 'Impact of Pharmacist-Led Intervention on Adult Oncology Outpatients' on April 20. Brief S... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550296) titled 'Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusio... Read More
Singapore, April 25 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the e... Read More
Singapore, April 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investiga... Read More
Singapore, April 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investiga... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550335) titled 'Group Reading and Oral Exercise Program for Older Adults' on April 19. Brief Summary: Dep... Read More
Singapore, April 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate ... Read More
Singapore, April 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550101) titled 'Social Equity Data in Primary Care: How Best to Collect Data From Hard-to-Reach Population... Read More
Singapore, April 25 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, ... Read More